Over the past year, many patients like Wright, who depend on insulin have encountered shortages, delays and red tape from ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

Recognition of the heterogeneous causes of diabetes should help improve prevention, treatment, and the ability to predict ...

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...

An oral formulation of semaglutide, taken daily, is more effective at reducing the risk of major adverse cardiovascular ...

A new treatment combining ReCET and semaglutide could eliminate the need for insulin in type 2 diabetes, with 86% of ...

The Wegovy makers’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in ...

The active ingredient in Ozempic and Wegovy has once again proven to have health effects outside of weight loss in a huge ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

A minorities-only study on a dual-action therapy for diabetic macular edema found Hispanic and Latino patients not only ...

Contrary to concerns, GLP-1RA medications don’t appear to elevate AKI risk in patients undergoing cancer treatment.

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They ...